Quoin Pharmaceuticals LT-ADRQNRX
13F holders, Q2 2026 (June 30)19holders −2
1new positions
3sold out
1famous investor
$4.84avg. 13F price*
At the end of Q2 2026, 19 institutions reported holding Quoin Pharmaceuticals LT-ADR (QNRX) in their 13F filings, down 2 from Q1 2026. 1 opened new positions and 3 sold out. The largest holders were Dauntless Investment Group, LLC ($1.0M), Ikarian Capital, LLC ($1.0M) and Stonepine Capital Management, LLC ($966K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Quoin Pharmaceuticals LT-ADR
- CUSIP
- 74907L409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $73K |
| Exits | 3 | $611K |
All 13F filers, Q1 2026 → Q2 2026: 264,096 shares bought and 149,424 shares sold, net +114,672 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Dauntless Investment Group, LLC | 1.80% | Add +9.4% | 214,987 | $1.0M |
| Ikarian Capital, LLC | 0.17% | No change | 211,538 | $1.0M |
| Stonepine Capital Management, LLC | 0.73% | Add +273.1% | 199,486 | $966K |
| Millennium Management | 0.00% | Add +47.3% | 112,323 | $544K |
| SummitTX Capital, L.P. | 0.01% | No change | 100,300 | $485K |
| Woodline Partners LP | 0.00% | Reduce -3.9% | 76,446 | $370K |
| Aberdeen Group plc | 0.00% | No change | 75,000 | $363K |
| Soleus Capital Management, L.P. | 0.01% | No change | 72,730 | $352K |
| AIGH Capital Management LLC | 0.03% | Add +37.3% | 70,000 | $339K |
| Boothbay Fund Management, LLC | 0.01% | No change | 59,838 | $290K |
| Velan Capital Investment Management LP | 0.10% | Reduce -61.9% | 32,372 | $157K |
| Barclays PLC | 0.00% | Add +1551.5% | 21,469 | $104K |
| Birchview Capital, LP | 0.05% | No change | 20,000 | $97K |
| XTX Topco Ltd | 0.00% | New | 15,006 | $73K |
| Morgan Stanley | 0.00% | Add +100.0% | 8,000 | $39K |
| UBS Group AG | 0.00% | Add +169.6% | 6,772 | $33K |
| Rhumbline Advisers | 0.00% | Add +53.3% | 2,332 | $11K |
| GAMMA Investing LLC | 0.00% | Reduce -74.5% | 439 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +17650.0% | 355 | $2K |
"% of holder's portfolio" is QNRX's weight in each manager's 13F, not the share of Quoin Pharmaceuticals LT-ADR the manager owns.